ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Journal and News Scan
January 20, 2022
Submitted by: Christopher Anderson
Socioeconomic and racial (SER) disparities among patients with congenital heart disease (CHD) can limit access to high-quality care. We characterized the national SER landscape and its relationship to early outcomes and identified interactions among determinants mitigating adverse outcome.
January 14, 2022
Submitted by: Aristotle Protopapas
A scholarly update on the previous (2016) guidelines, with an interesting Chapter 9 Gaps in evidence and future perspectives. The guidelines have been extensively reviewed by European and other experts. The authors insist on the only advisory value of their conclusions. Understandably, there is no mention of venous ECMO.
January 13, 2022
Submitted by: Christopher Anderson
This study looks to comprehensively characterize details of aortic and aortic valve reinterventions after aortic root replacement (ARR).
January 11, 2022
Submitted by: Wei-Guo Ma
On January 10, 2021, the University of Maryland School of Medicine annnounced that Dr. Bartley P. Griffith and his team successfully transplanted a genetically modified pig heart in a 57-year-old man with end-stage heart failure, and the patient was doing well three days later.
This historic xenotransplant operation may provide an important new option for patients with terminal heart disease in dire need of heart donor and a viable solution to the organ crisis.
January 11, 2022
Submitted by: Wei-Guo Ma
On January 10, 2021, the University of Maryland School of Medicine annnounced that Dr. Bartley P. Griffith and his team successfully transplanted a genetically modified pig heart in a 57-year-old man with end-stage heart failure, and the patient was doing well three days later. This historic xenotransplant operation may provide an important new option for patients in dire need of heart donor and a viable solution to the organ crisis.
January 6, 2022
Submitted by: Christopher Anderson
The Southern Thoracic Surgical Association (STSA) is a regional society whose mission is to support members of the cardiothoracic community. Since 1954, STSA has held its annual meeting to promote the scholarly work and networking of its members. This year, Donald D. Chang, MD PhD had the privilege of attending the 68th Annual Meeting as a James W. Brooks scholar, named in honor of the Society’s 23rd President for his lifelong support and contribution to the society. Here he gives his account of his experiecs at the event.
December 27, 2021
Submitted by: Christopher Anderson
The American Association for Thoracic Surgery and Society of Thoracic Surgeons share their reasoning for not endorsing the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines. To read these guidelines, click here.
December 27, 2021
Submitted by: Christopher Anderson
This is a letter from EACTS about the new ACC/AHA/SCAI guidelines. To ready these guidelines, click here.
December 25, 2021
Submitted by: Emily Farkas
The rising burden of CAD in low- and middle-income countries like Nigeria is a result of the epidemiological transition from communicable to non- communicable diseases. The system of care for acute coronary syndrome (ACS) is evolving and constrained by a lack of prehospital emergency services, prolonged intervention times, and low patient eligibility and infrastructural capacity for reperfusion. Management guidelines that are based on best practices in resource-endowed nations may not be implementable, with the consequence of frequent major adverse cardiac events and high mortality.
This observational multicentered national registry enrolled 1072 Nigerians with ACS to evaluate incidence, intervention times, reperfusion rates, and 1 year mortality. Recommendations are considered for preventative strategies and infrastructure-appropriate management guidelines.
December 17, 2021
Submitted by: Christopher Anderson
Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with this disease. The 2021 Coronary Artery Revascularization Guideline, released on December 9 by the American College of Cardiology, and American Heart Association, and the Society for Cardiovascular Angiography and Interventions, provides recommendations based on contemporary evidence for the treatment of these patients.